JP2005530736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530736A5 JP2005530736A5 JP2003585730A JP2003585730A JP2005530736A5 JP 2005530736 A5 JP2005530736 A5 JP 2005530736A5 JP 2003585730 A JP2003585730 A JP 2003585730A JP 2003585730 A JP2003585730 A JP 2003585730A JP 2005530736 A5 JP2005530736 A5 JP 2005530736A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- optionally substituted
- amount
- beta blocker
- esmolol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *c1c2nc[n](C([C@@]3O)O[C@@](CO)[C@@]3O)c2ncn1 Chemical compound *c1c2nc[n](C([C@@]3O)O[C@@](CO)[C@@]3O)c2ncn1 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37376602P | 2002-04-18 | 2002-04-18 | |
| PCT/US2003/012043 WO2003088978A1 (en) | 2002-04-18 | 2003-04-18 | Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530736A JP2005530736A (ja) | 2005-10-13 |
| JP2005530736A5 true JP2005530736A5 (https=) | 2006-06-01 |
Family
ID=29251078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003585730A Pending JP2005530736A (ja) | 2002-04-18 | 2003-04-18 | ベーターブロッカー、カルシウムチャネルブロッカー、または心臓のグリコシドと共にａ１アデノシンアゴニストを投与することを含む不整脈の処置方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US7005425B2 (https=) |
| EP (1) | EP1494685B1 (https=) |
| JP (1) | JP2005530736A (https=) |
| KR (1) | KR20040106354A (https=) |
| CN (2) | CN1646142A (https=) |
| AT (1) | ATE418991T1 (https=) |
| AU (1) | AU2003235466C1 (https=) |
| CA (1) | CA2482928A1 (https=) |
| DE (1) | DE60325572D1 (https=) |
| ES (1) | ES2318129T3 (https=) |
| IL (1) | IL164652A0 (https=) |
| MX (1) | MXPA04010285A (https=) |
| NO (1) | NO20045005L (https=) |
| NZ (1) | NZ536001A (https=) |
| RU (1) | RU2332220C2 (https=) |
| WO (1) | WO2003088978A1 (https=) |
| ZA (1) | ZA200408411B (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ514515A (en) | 1999-03-23 | 2003-11-28 | Global Cardiac Solutions Pty L | Organ arrest, protection and preservation using a potassium channel operator and/or adenosine receptor and a local anaesthetic |
| US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
| USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
| AU2001238665A1 (en) | 2000-02-23 | 2001-09-03 | Cv Therapeutics, Inc. | Method of identifying partial agonists of the a2a receptor |
| US7157440B2 (en) * | 2001-07-13 | 2007-01-02 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| US7713946B2 (en) * | 2002-07-11 | 2010-05-11 | Cv Therapeutics, Inc. | Partial and full agonists A1 adenosine receptors |
| ATE418991T1 (de) * | 2002-04-18 | 2009-01-15 | Cv Therapeutics Inc | Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker |
| US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
| GB2436255B (en) * | 2002-12-23 | 2007-11-28 | Global Cardiac Solutions Pty L | Organ preconditioning, arrest, protection, preservation and recovery |
| EP1768991A1 (en) * | 2004-07-12 | 2007-04-04 | Cv Therapeutics, Inc. | Process for the preparation of a1-adenosine receptor agonists |
| US20060019954A1 (en) * | 2004-07-20 | 2006-01-26 | Cedars-Sinai Medical Center | Method for reducing the likelihood of the occurrence of cardiac arrhythmias |
| US7300923B2 (en) * | 2004-08-30 | 2007-11-27 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| EP1802775B1 (en) | 2004-09-14 | 2010-05-26 | The Regents of the University of Colorado | Method for treatment with bucindolol based on genetic targeting |
| US7822474B2 (en) * | 2005-11-30 | 2010-10-26 | Cedars-Sinai Medical Center | Methods for the prediction of arrhythmias and prevention of sudden cardiac death |
| WO2007092372A1 (en) | 2006-02-03 | 2007-08-16 | Cv Therapeutics, Inc. | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
| AU2006345361B2 (en) | 2006-05-29 | 2014-04-10 | Hibernation Therapeutics, A Kf Llc | Improved tissue maintenance |
| CA2692256C (en) | 2006-07-25 | 2017-01-10 | Hibernation Therapeutics Limited | Trauma therapy |
| EP2173353B1 (en) | 2007-03-02 | 2015-05-06 | Hibernation Therapeutics, a KF LLC | Composition including Adenosine and Lignocaine |
| HRP20121045T1 (hr) | 2007-12-21 | 2013-01-31 | Aop Orphan Pharmaceuticals Ag | Farmaceutska smjesa za parenteralnu primjenu antagonista beta-adrenoreceptora ultrakratkog djelovanja |
| MX2011003168A (es) * | 2008-09-29 | 2011-05-19 | Gilead Sciences Inc | Combinaciones de un agente de control de cantidad y un antagonista del receptor a-2-alfa para utilizarse en metodos de tomografia computarizada de detectores multiples. |
| GB0903299D0 (en) | 2009-02-26 | 2009-04-08 | Guys And St Thomas Nhs Foundat | Composition and methods |
| CA2835771C (en) * | 2009-03-18 | 2017-01-24 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| US20110039799A1 (en) | 2009-08-14 | 2011-02-17 | Gilead Palo Alto, Inc. | A1 adenosine receptor agonist polymorphs |
| LT2523669T (lt) | 2010-01-11 | 2017-04-25 | Inotek Pharmaceuticals Corporation | Akispūdžio mažinimo būdas, derinys ir rinkinys |
| US8455457B2 (en) * | 2010-03-19 | 2013-06-04 | Inotek Pharmaceuticals Corporation | Combination compositions for reducing intraocular pressure |
| PH12012501906A1 (en) | 2010-03-26 | 2013-01-14 | Inotek Pharmaceuticals Corp | Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| US20120005128A1 (en) * | 2010-06-29 | 2012-01-05 | Sanofi | Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation |
| PT2807178T (pt) | 2012-01-26 | 2017-08-08 | Inotek Pharmaceuticals Corp | Polimorfos anidros de nitrato de (2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-dihidroxitetrahidrofuran-2-il)}metilo e seus processos de preparação |
| NZ630759A (en) | 2013-03-15 | 2017-07-28 | Inotek Pharmaceuticals Corp | Ophthalmic formulations comprising an a1 agonist |
| BR112016000809A2 (pt) | 2013-07-17 | 2017-08-22 | Hibernation Therapeuitics A Kf Llc | Método para tratar infecção, sepsia e lesão |
| AU2014361813A1 (en) * | 2013-12-13 | 2016-07-28 | Ralph ANKENMAN | Compositions and methods for treating dysregulated systems |
| CN114847965A (zh) | 2016-02-01 | 2022-08-05 | 英凯达治疗公司 | 电子监测联合吸入药理学疗法管理心律失常 |
| CN106370754B (zh) * | 2016-11-07 | 2019-03-08 | 西安科技大学 | 基于手性高效液相色谱-质谱/质谱技术定量检测布新洛尔光学异构体含量的方法 |
| CA3060702A1 (en) | 2017-05-10 | 2018-11-15 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| ES3040411T3 (en) | 2018-03-22 | 2025-10-30 | Incarda Therapeutics Inc | A novel method to slow ventricular rate |
| US10799138B2 (en) | 2018-04-05 | 2020-10-13 | University Of Maryland, Baltimore | Method of administering sotalol IV/switch |
| US10512620B1 (en) | 2018-08-14 | 2019-12-24 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US12396970B2 (en) | 2021-08-20 | 2025-08-26 | AltaThera Pharmaceuticals LLC | Anti-arrhythmic compositions and methods |
| US11344518B2 (en) | 2018-08-14 | 2022-05-31 | AltaThera Pharmaceuticals LLC | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
| JP7156154B2 (ja) * | 2019-04-18 | 2022-10-19 | 株式会社島津製作所 | 培地処理システム及び培地処理方法 |
| US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| KR102891439B1 (ko) | 2019-08-01 | 2025-11-25 | 인카다 테라퓨틱스, 인크. | 항부정맥 제제 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
| US5736528A (en) * | 1993-10-28 | 1998-04-07 | University Of Florida Research Foundation, Inc. | N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists |
| EP0907644A4 (en) * | 1996-06-28 | 2003-02-05 | Merck & Co Inc | PHARMACEUTICAL PREPARATION |
| US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
| JP2001509808A (ja) * | 1997-01-31 | 2001-07-24 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 多機能性カルシウム／カルモジュリン−依存性プロテインキナーゼの阻害による不整脈の処置 |
| CO5180581A1 (es) * | 1999-09-30 | 2002-07-30 | Pfizer Prod Inc | Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia |
| US6576620B2 (en) * | 1999-12-03 | 2003-06-10 | Cv Therapeutics, Inc. | Method of identifying partial adenosine A1 receptor agonists |
| US6605597B1 (en) * | 1999-12-03 | 2003-08-12 | Cv Therapeutics, Inc. | Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives |
| US6537974B2 (en) * | 2000-09-08 | 2003-03-25 | Cv Therapeutics, Inc. | Method of treating arrhythmias |
| US6946449B2 (en) | 2001-07-13 | 2005-09-20 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| ATE418991T1 (de) * | 2002-04-18 | 2009-01-15 | Cv Therapeutics Inc | Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker |
-
2003
- 2003-04-18 AT AT03724098T patent/ATE418991T1/de not_active IP Right Cessation
- 2003-04-18 CN CNA038086999A patent/CN1646142A/zh active Pending
- 2003-04-18 DE DE60325572T patent/DE60325572D1/de not_active Expired - Lifetime
- 2003-04-18 RU RU2004130826/14A patent/RU2332220C2/ru not_active IP Right Cessation
- 2003-04-18 EP EP03724098A patent/EP1494685B1/en not_active Expired - Lifetime
- 2003-04-18 CN CNA2008101711378A patent/CN101385738A/zh active Pending
- 2003-04-18 AU AU2003235466A patent/AU2003235466C1/en not_active Ceased
- 2003-04-18 MX MXPA04010285A patent/MXPA04010285A/es active IP Right Grant
- 2003-04-18 KR KR10-2004-7016764A patent/KR20040106354A/ko not_active Abandoned
- 2003-04-18 US US10/418,654 patent/US7005425B2/en not_active Expired - Fee Related
- 2003-04-18 JP JP2003585730A patent/JP2005530736A/ja active Pending
- 2003-04-18 NZ NZ536001A patent/NZ536001A/en not_active IP Right Cessation
- 2003-04-18 CA CA002482928A patent/CA2482928A1/en not_active Abandoned
- 2003-04-18 ES ES03724098T patent/ES2318129T3/es not_active Expired - Lifetime
- 2003-04-18 WO PCT/US2003/012043 patent/WO2003088978A1/en not_active Ceased
-
2004
- 2004-10-18 ZA ZA200408411A patent/ZA200408411B/en unknown
- 2004-10-18 IL IL16465204A patent/IL164652A0/xx unknown
- 2004-11-17 NO NO20045005A patent/NO20045005L/no not_active Application Discontinuation
-
2005
- 2005-10-28 US US11/262,025 patent/US7479485B2/en not_active Expired - Fee Related
-
2009
- 2009-01-09 US US12/351,731 patent/US20090118221A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005530736A5 (https=) | ||
| CN104470939B (zh) | 用于肝脏疾病的d型氨基酸化合物 | |
| RU2004130826A (ru) | Способ лечения аритмии, включающий введение агониста рецептора аденозина а1 вместе с бета-блокатором, блокатором кальциевых каналов или сердечным гликозидом | |
| US9416154B2 (en) | 5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| AU2012357940B2 (en) | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication | |
| US9408863B2 (en) | 5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases | |
| JP4021195B2 (ja) | 部分もしくは完全ａ１アゴニスト：ｎ６複素環式５′−チオ置換アデノシン誘導体 | |
| CN105085592B (zh) | N-[(2`r)-2`-脱氧-2`-氟-2`-甲基-p-苯基-5`-尿苷酰基]-l-丙氨酸1-甲基乙基酯及其制备方法 | |
| US9061041B2 (en) | 2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| KR101320008B1 (ko) | ３，５-이치환 및 ３，５，７-삼치환된-３Ｈ-옥사졸로 및３Ｈ-티아졸로 〔４，５-ｄ〕피리미딘-2-온 화합물 및 이의전구약물 | |
| KR20230170015A (ko) | 항바이러스제로서의 뉴클레오시드 및 뉴클레오티드 유사체 | |
| DK2794628T3 (en) | 4'-AZIDO-3'-FLUORO-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION | |
| CN108350016B (zh) | 抗病毒四氢呋喃衍生物 | |
| CN111848711A (zh) | 用于hcv感染的2′-氯核苷类似物 | |
| TW201811339A (zh) | 經取代之核苷、核苷酸及其類似物 | |
| TW201418274A (zh) | ２’－甲基經取代之核苷衍生物及其用於治療病毒疾病之使用方法 | |
| US10683321B2 (en) | 4′-or nucleosides for the treatment of HCV | |
| US20140356325A1 (en) | Novel 2'-c-methyl nucleoside derivative compounds | |
| CN107108683A (zh) | 用于治疗黄病毒科病毒和癌症的2’,2’‑二卤代核苷类似物 | |
| CN102089318B (zh) | Hiv抑制剂化合物的盐 | |
| CN106536538A (zh) | 用于治疗黄病毒家族病毒和癌症的2’‑双取代核苷类似物 | |
| HK1048821A1 (en) | Thiophene a2a receptor agonists | |
| CN101240001B (zh) | 2'-氟代核苷 | |
| JP2006505525A5 (https=) | ||
| WO2026011167A1 (en) | Thionucleosides as antiviral agents |